Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.

ABSTRACT: Enoyl-acyl carrier protein reductase (ENR), a critical enzyme in type II fatty acid biosynthesis, is a promising target for drug discovery against hepatocyte-stage Plasmodium falciparum. In order to identify PfENR-specific inhibitors, we docked 70 FDA-approved, bioactive, and/or natural product small molecules known to inhibit the growth of whole-cell blood-stage P. falciparum into several PfENR crystallographic structures. Subsequent in vitro activity assays identified a noncompetitive low-micromolar PfENR inhibitor, celastrol, from this set of compounds.

SUBMITTER: Tallorin LC 

PROVIDER: S-EPMC4807855 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature